Income Statement
PASSAGE BIO, INC.
PASG
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - |
|
Operating Expenses
|
43.15 | 65.17 | 41.58 | 49.34 | 60.06 | 30.11 |
|
Research & Development
|
23.28 | 40.18 | 61.42 | 86.05 | 117.67 | 81.79 |
|
Selling, General & Administrative
|
19.88 | 24.99 | 41.58 | 49.34 | 60.06 | 30.11 |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-43.15 | -65.17 | -41.58 | -49.34 | -60.06 | -30.11 |
|
Non-Operating Income
|
- | - | - | - | - | - |
|
Interest Income
|
- | - | - | - | 0.34 | 0.67 |
|
Interest Expense
|
- | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
3.80 | 5.63 | 6.33 | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - |
|
Net Income
|
-45.52 | -64.77 | -102.06 | -136.13 | -185.39 | -112.23 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-42.42 | -62.07 | -37.86 | -45.64 | -58.51 | -29.31 |
|
Earnings Per Share (Basic)
|
-14.35 | -1.07 | -1.86 | -2.50 | -3.48 | - |
|
Diluted EPS
|
-14.35 | -1.07 | -1.86 | -2.50 | -3.48 | - |
|
Weighted Average Shares
|
3.17 | 60.41 | 54.74 | 54.43 | 53.34 | - |
|
Diluted Weighted Avg Shares
|
3.17 | 60.41 | 54.74 | 54.43 | 53.34 | - |
|
Comprehensive Income
|
-45.53 | -64.72 | -101.14 | -136.68 | -185.79 | -112.24 |